Five Minutes with Saharsh Davuluri…
Saharsh Davuluri was interviewed for the ‘Show Daily’ magazine that was freely distributed at the inaugural CPhI North America / InformEx 2017 show, held in Philadelphia last month.
Click here to read the interview with our Joint Managing Director that appeared in the publication.
Neuland Labs celebrates the 43rd World Environment Day
On the occasion of 43rd World Environment Day celebrated on 5 June, 2017, as a responsible organization, we conducted various programs to create an awareness among the employees about protection of our environment.
This year in addition to the plantation and other programs, we organized a rally in Bonthapally where 125 NLL employees from Unit I and R&D participated. Unit II employees participated in a rally organized by TSPCB & TSIIC in Pashamylaram.
Neuland’s efforts to spread awareness about the importance and protection of our environment was hugely appreciated and the programs were published in two Telugu newspapers.
A great start to Philadelphia CPhI 2017
We have lots of appointments and the possibility of doing even more business in the worlds biggest pharma market. We will keep you posted but all is in good shape so far.
To stay ahead of the evolving needs and demands of the pharmaceutical and biotechnology industries the contract manufacturing organizations (CMOs), need to continuously adapt new trends. Saharsh Davuluri, Joint Managing Director, sheds light on the changes in the API manufacturing and how a CMO can adapt to the changes in the article “Navigating the Shifting Landscape of Contract API Manufacturing” on the Contract Pharma website. You can read the article by clicking here
Quality is of utmost importance. Focusing on quality in every step of manufacturing, Neuland boasts of two USFDA and EU GMP-compliant manufacturing facilities. Read more about our stringent quality control in the article “No Compromise APIs” on the Pharmaceutical Manufacturing website by clicking here
On-Demand Webcast: Reversed-Phase Liquid Chromatography Using Surrogate (Additional) Stationary Phases
Neuland recently sponsored the above-mentioned webinar on Liquid Chromatography. You can view an executive summary of the webinar by downloading this PDF file (Adobe Acrobat required) or view the webcast in full (on-demand) by completing the registration details here.
CPhI 2016 – Neuland in Barcelona meant business
With the hype now behind us we can confirm that Barcelona CPHI 2016, proved to be a fantastic success for Neuland. Our hugely impressive stand witnessed a continuous stream of customers for most of the three days and was completely packed. In particular, the “100 % API Provider” campaign proved a great hit. It was quite refreshing to see that Neuland continued to be a 100% API producer while many of the competitors were showcasing mixed messages.
We responded to every opportunity enthusiastically and this event proved we put our customers at the centre of our thoughts.
Many of the 20,000 people using Fira station noticed the high impact Neuland advertisement. Customers also commented on the station advertisement as a massive awareness generator for the already well-known Neuland brand.
A lot of the customers made it to an after show event at the history museum in central Barcelona. We were treated to a wonderful display of over 2000 years of history.
A big thank you to all customers and staff who collaborated, as you may expect, with a lot of hard work and diligence to make CPHI 2016 a grand success.
CPhI Madrid 2015 – 100% pure play record at CPhI proves a great success
Sometimes the obvious focus of your business needs reinforcing with a strong message and this was definitely the case at the CPhI.
Neuland took out a powerful advertising campaign on the illuminated signs on line 8 and at the main station next to the CPhI.
In addition, our API message was beamed out to 48k attendees in the show daily e blast.
The campaign reinforces our credentials as one of the few established main API players who focus entirely on API for clients. It is so easy to get distracted by FDF or selling direct to the market to improve margins.
Sometimes this can prove at odds with clients and partners who like to see a clear division between trade suppliers and those that inhabit the same direct marketing space.
As per usual at Neuland, we tried to make our land of opportunity different to those that love to see rows of reactors. We understand that people have equipment and they produce molecules of varying complexity. We are happy with what we can achieve for clients because we have world class peptide R&D and CMS which complements our formidable reactor capacity.
The human capital at Neuland is what makes this land of real opportunity for clients as well as for would be starters in the industry.
We are pleased to announce our 9th successful FDA audit along with winning the 2015 CMO Leadership award for Quality
CPhI Paris 2014
We would like to thank everyone who came to visit us at CPhI in Paris. The show was a great success and we look forward to seeing you all again soon. Below are some photos from this years show.
CMO Leadership Award
Q3 FY 16 Press Release
Q2 FY 16 Press Release
Q1 FY 16 Press Release
Neuland Labs reports fourth quarter fiscal year 2015 financial results
Neuland Labs reports third quarter fiscal year 2015 financial results
FDA & CMO Award Press Release - 26th Jan 2015
Neuland Labs reports second quarter fiscal year 2015 financial results
Neuland Labs reports first quarter fiscal year 2015 financial results
Neuland Labs reports financial results for fiscal year 2014
Neuland Labs inaugurates new manufacturing facility constructed for its collaboration with Mitsubishi Healthcare Unit API Corporation
Draft letter of offer
Neuland Labs reports third quarter fiscal year 2014 financial results
Neuland Labs reports second quarter fiscal year 2014 financial results
Neuland Labs' track record of cGMP excellence complemented by 2013 CMO Leadership award for regulatory excellence
Neuland Labs reports financial results for fiscal year 2014
Neuland Labs - manufacturing collaboration with mitsubishi healthcare unit api corporation
Neuland Labs reports financial results for fiscal year 2013